These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12385967)

  • 1. The use of extended amino acid motifs for focussing on toxic peptides in coeliac disease.
    McLachlan A; Cullis PG; Cornell HJ
    J Biochem Mol Biol Biophys; 2002 Oct; 6(5):319-24. PubMed ID: 12385967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wheat gliadin fractions and other cereal antigens reactive with antibodies in the sera of coeliac patients.
    Kieffer M; Frazier PJ; Daniels NW; Coombs RR
    Clin Exp Immunol; 1982 Dec; 50(3):651-60. PubMed ID: 7166001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-gliadin antibody specificity for gluten-derived peptides toxic to coeliac patients.
    Devery JM; La Brooy JT; Krillis S; Davidson G; Skerritt JH
    Clin Exp Immunol; 1989 Jun; 76(3):384-90. PubMed ID: 2752594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive antinutritional peptides derived from cereal prolamins: a review.
    Silano M; De Vincenzi M
    Nahrung; 1999 Jun; 43(3):175-84. PubMed ID: 10399351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural specificities and significance for coeliac disease of wheat gliadin peptides able to agglutinate or to prevent agglutination of K562(S) cells.
    De Vincenzi M; Stammati A; Luchetti R; Silano M; Gasbarrini G; Silano V
    Toxicology; 1998 May; 127(1-3):97-106. PubMed ID: 9699797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The precipitating factor in coeliac disease.
    Wieser H
    Baillieres Clin Gastroenterol; 1995 Jun; 9(2):191-207. PubMed ID: 7549024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Spelt wheat and celiac disease].
    Forssell F; Wieser H
    Z Lebensm Unters Forsch; 1995 Jul; 201(1):35-9. PubMed ID: 7571865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gluten-sensitive enteropathy.
    Luchetti R; De Vincenzi M
    Ann Ist Super Sanita; 1995; 31(3):323-36. PubMed ID: 8712576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of alpha-gliadin-derived peptides from bread and durum wheat on K562(S) cells.
    Dessi M; De Vincenzi M; Maialetti F; Mancini E
    Ital J Gastroenterol; 1992 Sep; 24(7):397-9. PubMed ID: 1392022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovative approach to low-level gluten determination in foods using a novel sandwich enzyme-linked immunosorbent assay protocol.
    Valdés I; García E; Llorente M; Méndez E
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):465-74. PubMed ID: 12702901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative toxicity of different cereals for subjects intolerant of gluten].
    Charbonnier L; Jos J; Mougenot JF; Mossé J
    Reprod Nutr Dev (1980); 1980; 20(4B):1369-77. PubMed ID: 6818635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry, coeliac-toxicity and detection of gluten and related prolamins in foods.
    Skerritt JH; Devery JM; Hill AS
    Panminerva Med; 1991; 33(2):65-74. PubMed ID: 1923557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coeliac disease: characterisation of monoclonal antibodies raised against a synthetic peptide corresponding to amino acid residues 206-217 of A-gliadin.
    Ellis HJ; Doyle AP; Sturgess RP; Ciclitira PJ
    Gut; 1992 Nov; 33(11):1504-7. PubMed ID: 1280610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coeliac Disease: background and biochemical aspects.
    Hamer RJ
    Biotechnol Adv; 2005 Sep; 23(6):401-8. PubMed ID: 16006084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A small peptide from durum wheat gliadin prevents cell agglutination induced by prolamin-peptides toxic in coeliac disease.
    De Vincenzi M; Gasbarrini G; Silano V
    Toxicology; 1997 Jul; 120(3):207-13. PubMed ID: 9217307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barley and rye prolamins induce an mRNA interferon-gamma response in coeliac mucosa.
    Bracken SC; Kilmartin C; Wieser H; Jackson J; Feighery C
    Aliment Pharmacol Ther; 2006 May; 23(9):1307-14. PubMed ID: 16629935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A radioimmunoassay for wheat gliadin to assess the suitability of gluten free foods for patients with coeliac disease.
    Ciclitira PJ; Ellis HJ; Evans DJ; Lennox ES
    Clin Exp Immunol; 1985 Mar; 59(3):703-8. PubMed ID: 3987095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of the presence of coeliac-activating gliadin-like epitopes in malted barley.
    Ellis HJ; Doyle AP; Day P; Wieser H; Ciclitira PJ
    Int Arch Allergy Immunol; 1994 Jul; 104(3):308-10. PubMed ID: 7518270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coeliac disease. Pathogenesis and clinical aspects.
    Friis SU
    APMIS Suppl; 1996; 61():1-48. PubMed ID: 8765057
    [No Abstract]   [Full Text] [Related]  

  • 20. Extraction of cereal prolamins and their toxicity in coeliac disease.
    Cornell HJ; McLachlan A; Cullis PG
    J Biochem Mol Biol Biophys; 2002 Apr; 6(2):151-8. PubMed ID: 12186773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.